Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 36602960)

  • 1. Food for thought-The link between Clostridioides difficile metabolism and pathogenesis.
    Marshall A; McGrath JW; Graham R; McMullan G
    PLoS Pathog; 2023 Jan; 19(1):e1011034. PubMed ID: 36602960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Stickland Reaction Precursor
    Reed AD; Fletcher JR; Huang YY; Thanissery R; Rivera AJ; Parsons RJ; Stewart AK; Kountz DJ; Shen A; Balskus EP; Theriot CM
    mSphere; 2022 Apr; 7(2):e0092621. PubMed ID: 35350846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.
    Passmore IJ; Letertre MPM; Preston MD; Bianconi I; Harrison MA; Nasher F; Kaur H; Hong HA; Baines SD; Cutting SM; Swann JR; Wren BW; Dawson LF
    PLoS Pathog; 2018 Sep; 14(9):e1007191. PubMed ID: 30208103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
    Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
    Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short chain fatty acid-centric view of Clostridioides difficile pathogenesis.
    Gregory AL; Pensinger DA; Hryckowian AJ
    PLoS Pathog; 2021 Oct; 17(10):e1009959. PubMed ID: 34673840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
    Theriot CM; Young VB
    Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.
    Lopez CA; Beavers WN; Weiss A; Knippel RJ; Zackular JP; Chazin W; Skaar EP
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
    Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
    [No Abstract]   [Full Text] [Related]  

  • 13. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Cheng JKJ; Unnikrishnan M
    Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
    [No Abstract]   [Full Text] [Related]  

  • 15. The microbial-derived bile acid lithocholate and its epimers inhibit
    Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
    J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856
    [No Abstract]   [Full Text] [Related]  

  • 16. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel p-cresol inhibitors that reduce Clostridioides difficile's ability to compete with species of the gut microbiome.
    Harrison MA; Farthing RJ; Allen N; Ahern LM; Birchall K; Bond M; Kaur H; Wren BW; Bergeron JRC; Dawson LF
    Sci Rep; 2023 Jun; 13(1):9492. PubMed ID: 37303029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jenior ML; Leslie JL; Young VB; Schloss PD
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.